Mikeljon Nikolich

Chief, Bacteriophage Therapeutics, Wound Infections Dept.

Walter Reed Army Institute of Research

United States

Research Interests

Explore related searches

Professors in United States Professors in Microbiology Microbiology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Mikeljon Nikolich is the Chief of Bacteriophage Therapeutics at the Wound Infections Department of the Walter Reed Army Institute of Research in the United States. His research primarily focuses on bacteriophage therapy, particularly in relation to multidrug-resistant bacteria such as Klebsiella pneumoniae and Pseudomonas aeruginosa . Recent publications include the genome sequencing of various bacteriophages and studies investigating their therapeutic potential in treating infections related to cystic fibrosis.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Collaborators (1)

Derrick Fouts

Professor

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Mikeljon Nikolich

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Genome sequence of staphylococcal phage ESa4 of the genus Rosenblumvirus

Phage Host Range Expansion Through Directed Evolution on Highly Phage-Resistant Strains of <i>Klebsiella pneumoniae</i>

Genome sequences of two phages active against cystic fibrosis isolates of Pseudomonas aeruginosa

Complete genome sequences of three Pseudomonas aeruginosa phages of the genus Phikmvvirus

Genome sequences of five Klebsiella bacteriophages that belong to the genus Jiaodavirus

Complete genome sequences of three Pseudomonas aeruginosa jumbo bacteriophages discovered in Kenya

Correlation of Pseudomonas aeruginosa Phage Resistance with the Numbers and Types of Antiphage Systems

Interlaboratory comparison of Pseudomonas aeruginosa phage susceptibility testing

Design of a Bacteriophage Cocktail Active against <i>Shigella</i> Species and Testing of Its Therapeutic Potential in <i>Galleria mellonella</i>

Safety and microbiological activity of phage therapy in persons with cystic fibrosis colonized with Pseudomonas aeruginosa: study protocol for a phase 1b/2, multicenter, randomized, double-blind, placebo-controlled trial

Collaborators (1)

Derrick Fouts

Make your next move.